Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma
Public ClinicalTrials.gov record NCT01740297. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1b/2, Multicenter, Open-label Trial to Evaluate the Safety and Efficacy of Talimogene Laherparepvec and Ipilimumab Compared to Ipilimumab Alone in Subjects With Unresected, Stage IIIB-IV Melanoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 1b of the study will evaluate the safety of talimogene laherparepvec in combination with ipilimumab. Phase 2 is a randomized study that will evaluate the safety and efficacy of talimogene laherparepvec in combination with ipilimumab versus ipilumumab alone.
Study identification
- NCT ID
- NCT01740297
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 217 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 6, 2013
- Primary completion
- Aug 22, 2016
- Completion
- Mar 8, 2021
- Last update posted
- May 13, 2024
2013 – 2021
United States locations
- U.S. sites
- 32
- U.S. states
- 20
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tucson | Arizona | 85724 | — |
| Research Site | Beverly Hills | California | 90211 | — |
| Research Site | Los Angeles | California | 90025 | — |
| Research Site | Los Angeles | California | 90089-2211 | — |
| Research Site | Los Angeles | California | 90095 | — |
| Research Site | San Francisco | California | 94115 | — |
| Research Site | Santa Rosa | California | 95403 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Jacksonville | Florida | 32207 | — |
| Research Site | Jacksonville | Florida | 32224 | — |
| Research Site | Lakeland | Florida | 33805 | — |
| Research Site | Miami | Florida | 33140 | — |
| Research Site | Chicago | Illinois | 60612 | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | Indianapolis | Indiana | 46260 | — |
| Research Site | Iowa City | Iowa | 52242 | — |
| Research Site | Louisville | Kentucky | 40202 | — |
| Research Site | Minneapolis | Minnesota | 55407 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Research Site | Morristown | New Jersey | 07962 | — |
| Research Site | New Brunswick | New Jersey | 08903 | — |
| Research Site | New York | New York | 10029 | — |
| Research Site | New York | New York | 10032 | — |
| Research Site | Chapel Hill | North Carolina | 27599 | — |
| Research Site | Canton | Ohio | 44718 | — |
| Research Site | Cincinnati | Ohio | 45267 | — |
| Research Site | Charleston | South Carolina | 29425 | — |
| Research Site | Nashville | Tennessee | 37232 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | Salt Lake City | Utah | 84112 | — |
| Research Site | Richmond | Virginia | 23298-0037 | — |
| Research Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01740297, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2024 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01740297 live on ClinicalTrials.gov.